TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 47 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $541,000 | +47.8% | 4,675 | +26.2% | 0.00% | +100.0% |
| Q1 2018 | $366,000 | -66.3% | 3,703 | -64.3% | 0.00% | -75.0% |
| Q4 2017 | $1,086,000 | -35.0% | 10,372 | -11.4% | 0.00% | -55.6% |
| Q3 2015 | $1,672,000 | +3.3% | 11,700 | +3.9% | 0.01% | +12.5% |
| Q2 2015 | $1,618,000 | +446.6% | 11,260 | +435.7% | 0.01% | +700.0% |
| Q1 2015 | $296,000 | -75.3% | 2,102 | -74.0% | 0.00% | -85.7% |
| Q4 2014 | $1,197,000 | -63.8% | 8,075 | -62.4% | 0.01% | -53.3% |
| Q3 2014 | $3,304,000 | +481.7% | 21,471 | +111.2% | 0.02% | +275.0% |
| Q2 2013 | $568,000 | – | 10,168 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 85,205 | $9,416,000 | 7.01% |
| FORT, L.P. | 149,014 | $16,468,000 | 5.67% |
| Strategic Global Advisors, LLC | 80,231 | $11,336,000 | 4.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 701,900 | $77,567,000 | 3.19% |
| Ativo Capital Management LLC | 78,727 | $8,700,000 | 2.01% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,474,000 | 1.47% |
| Parametrica Management Ltd | 4,327 | $478,000 | 1.32% |
| Freestone Capital Holdings, LLC | 89,005 | $9,836,000 | 0.90% |
| RPG Investment Advisory, LLC | 19,580 | $2,163,000 | 0.68% |
| MERITAGE PORTFOLIO MANAGEMENT | 38,465 | $4,251,000 | 0.47% |